ISOLATION OF THE GENE FOR CHEDIAK-HIGASHI SYNDROME
ISOLATION OF THE GENE FOR CHEDIAK-HIGASHI SYNDROME
批准号:
3082903
负责人:
RANDALL F HOLCOMBE
金额:
$7.56万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-09-01 至 1994-08-31
关键词:
Chediak Higashi syndrome T lymphocyte complementary DNA cytogenetics disease /disorder model female gel electrophoresis gene expression gene therapy genetic disorder genetic disorder diagnosis genetic library genetic manipulation genetic mapping genetic markers genetic transcription homeostasis human genetic material tag human tissue immunodeficiency laboratory mouse linkage mapping molecular cloning northern blottings nucleic acid probes nucleic acid sequence prenatal diagnosis recombinant DNA restriction fragment length polymorphism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Chediak-Higashi syndrome (CHS) is a rare immuno-deficiency disease with
manifestations involving alterred hemostasis, an increase in the frequency
of malignancies, abnormal function of lysosomes with resultant lack of
"Natural Killer" activity, and an increase in a specific subset of
T-lymphocytes. The gene responsible for the syndrome has not been
characterized in either the human or murine system, although the
chromosomal location of the gene causing the analogous syndrome in mice
(bg) has been identified.
The goals of this project are: 1) Generate a murine "jumping library" to
identify new probes close to bg, 2) Define restriction fragment length
polymorphisms (RFLP) with these probes through cross hybridization with
human DNA, 3) Determine genetic linkage of the probes to the CHS gene by
RFLP and family analysis, 4) analyze human and murine northern blots to
identify transcripts of the putative gene and 5) sequence putative CHS
genes and predict the protein product.
The technology for identifying a gene by "reverse genetics" on the basis of
its chromosomal location exists and should be facilitated in this instance
by the presence of an animal model for which the gene has been previously
mapped. Identification of the CHS gene should provide information about
hemostasis, immune surveillance, lysosomal function, and the in vivo
function of gamma delta T-lymphocytes.
Dr. Randall Holcombe is completing training in the medical subspecialties
of hematology and oncology and has already initiated a productive research
program concerning CHS. He has developed expertise in the molecular
biological techniques required for the successful completion of the
research program described herein over the prior two years. The Department
of Genetics, where the bulk of the research will be performed, has the
equipment necessary for recombinant DNA research, with tissue culture and
animal facilities. The Hematology Division and the Department of Genetics
sponsor journal clubs, lab meetings, and several lecture series, and
provide an exciting and stimulating environment for research.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Chronic myelomonocytic leukemia transformation in polycythemia vera.
慢性粒单核细胞白血病转化为真性红细胞增多症。
DOI:
--
发表时间:
1991
期刊:
Leukemia
影响因子:
11.4
作者:
[Holcombe,RF, Treseler,PA, Rosenthal,DS]
通讯作者:
Rosenthal,DS
Linkage of loci associated with two pigment mutations on mouse chromosome 13.
与小鼠 13 号染色体上两个色素突变相关的基因座的连锁。
DOI:
10.1017/s0016672300029591
发表时间:
1991
期刊:
Genetical research
影响因子:
--
作者:
[Holcombe,RF, Stephenson,DA, Zweidler,A, Stewart,RM, Chapman,VM, Seidman,JG]
通讯作者:
Seidman,JG
Mechanisms of calcium antagonist-induced vasodilation.
钙拮抗剂诱导血管舒张的机制。
DOI:
10.1146/annurev.pa.23.040183.002105
发表时间:
1983
期刊:
Annual review of pharmacology and toxicology
影响因子:
12.5
作者:
[Cauvin,C, Loutzenhiser,R, VanBreemen,C]
通讯作者:
VanBreemen,C
Lysosomal enzyme activities in Chediak-Higashi syndrome: evaluation of lymphoblastoid cell lines and review of the literature.
Chediak-Higashi 综合征中的溶酶体酶活性:类淋巴母细胞系的评估和文献综述。
DOI:
--
发表时间:
1994
期刊:
Immunodeficiency
影响因子:
--
作者:
[Holcombe,RF, Jones,KL, Stewart,RM]
通讯作者:
Stewart,RM
Neoadjuvant photodynamic immunomodulation for colon cancer
-
批准号:8005456
-
项目类别:
-
资助金额:$29.82万
-
财政年份:2010
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Neoadjuvant photodynamic immunomodulation for colon cancer
-
批准号:8119595
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2010
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON
-
批准号:8166926
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2009
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON
-
批准号:7951074
-
项目类别:
-
资助金额:$6.51万
-
财政年份:2008
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
A Phase 1 Study of CCI-779 in Combination with Imatnib *
-
批准号:7087072
-
项目类别:
-
资助金额:$24.88万
-
财政年份:2005
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Wnt Signaling in IBD-Related Colon Cancer
-
批准号:6850894
-
项目类别:
-
资助金额:$15.19万
-
财政年份:2004
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Wnt Signaling in IBD-Related Colon Cancer
-
批准号:6703346
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2004
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6327470
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6874525
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7586771
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7097832
-
项目类别:
-
资助金额:$14.58万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6633466
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:8182171
-
项目类别:
-
资助金额:$9.12万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7251986
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7788097
-
项目类别:
-
资助金额:$5.84万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7386702
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6514090
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6726005
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
University of Hawaii Cancer Center CCSG
-
批准号:9268835
-
项目类别:
-
资助金额:$11.55万
-
财政年份:1997
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
University of Hawaii Cancer Center CCSG
-
批准号:9526161
-
项目类别:
-
资助金额:$215.6万
-
财政年份:1997
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
海外基金